[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362035-105":59,"doc-detail-362035-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","enhancing-the-sensitivity-of-noninvasive-cervical-cancer-detection-using-cpg-methylation-haplotype-profiling","Enhancing the sensitivity of noninvasive cervical cancer detection using CpG methylation haplotype profiling","","DNA methylation serves as a key epigenetic regulator and supports cancer development and early detection. In non-invasive cervical cancer sampling, tumor-derived DNA is diluted by normal DNA, reducing sensitivity of ratio-based methylation assays, especially in early-stage disease. This study applies Highly Methylated Haplotype (HMH) profiling with next-generation sequencing to a four-biomarker gene panel, achieving higher sensitivity for invasive cancer and clinically relevant CIN2+ and CIN3+ endpoints than median or single-CpG scoring.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-the-sensitivity-of-noninvasive-cervical-cancer-detection-using-cpg-methylation-haplotype-profiling/362035/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-the-sensitivity-of-noninvasive-cervical-cancer-detection-using-cpg-methylation-haplotype-profiling/362035.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why do existing DNA methylation detection methods have limited sensitivity in early cervical cancer?","Question",{"text":113,"@type":114},"Early tumors yield low concentrations of cancer DNA, and clinical samples contain a large background of normal DNA. Ratio-based methods can smooth subtle methylation differences, producing false negatives when tumor signals are weak.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the Highly Methylated Haplotype (HMH) approach used in this study?",{"text":118,"@type":114},"HMH profiling captures highly methylated haplotypes at single-molecule resolution using next-generation sequencing. It distinguishes cancer-associated methylation patterns from sporadic methylation seen in non-cancerous tissues.",{"name":120,"@type":111,"acceptedAnswer":121},"Which biomarkers were included in the gene panel and how did performance compare to other scoring methods?",{"text":122,"@type":114},"The panel included CA10, DPP10, FMN2, and HAS1. Haplotype-based scoring at pre-specified cutoffs achieved 89.9% sensitivity for invasive cancer with high specificity (about 94–98%), outperforming median and single-CpG approaches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},362035,1790211997,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEnhancing the sensitivity of noninvasive cervical cancer detection using CpG methylation haplotype profiling  \nDavid Cheishvili1,2,3􀀍, Mariam El-Zein3,4, Eduardo L. Franco3,4 & Moshe Szyf1,2,5,6,7  \nDNA methylation is a critical epigenetic modification that regulates gene expression and plays a significant role in cancer development. This methylation signature can be detected in cancer-derived DNA from non-invasive samples, such as plasma, urine or Pap smears. However, in early-stage cancers—when detection is most critical—the concentration of cancer DNA is often low, limiting the sensitivity of current detection methods. Traditional DNA methylation detection techniques, which rely on methylation ratio-based measurements, may obscure subtle variations in methylation patterns, further reducing detection sensitivity. In this study, we analyzed cervical scraping specimens and examined whether detecting cancer-specific methylation patterns in cervical cancer could be enhanced using a Highly Methylated Haplotype (HMH) approach. This novel approach captures highly methylated haplotypes at single-molecule resolution using next-generation sequencing, providing greater detail than conventional methods. HMHs in specific DNA regions are a hallmark of cancer and stand out in contrast to sporadic methylation commonly observed in non-cancerous tissues. We applied HMH profiling to a gene panel of four biomarkers (CA10, DPP10, FMN2, and HAS1) previously validated in cervical cancer studies. At pre-specified cutoffs (99th percentile of normals), haplotype-based scoring achieved 89.9% sensitivity for invasive cancer at high specificity (~ 94–98%), outperforming median (78.0%) and single-CpG (71.6%) methods. For clinically relevant endpoints, the combined panel detected 51–52% ofCIN2 + and 66–67% ofCIN3+ cases, again exceeding the performance of median-and single-CpG-based scoring methods.  \nThese findings demonstrate the potential of HMH to substantially enhance sensitivity in cervical cancer detection, offering a promising approach for non-invasive diagnostics.  \nKeywords Cervical cancer screening, Cervical intraepithelial neoplasia, DNA methylation, Next-generation sequencing, Haplotypes  \nDNA methylation is a critical epigenetic modification that may affect gene expression at key positions in the genome 1,2. During the progression from normal to malignant cells, significant alterations in DNA methylation patterns occur, which are a hallmark of cancer development. These changes provide valuable biomarkers for the early detection of cancer 3. Traditional approaches primarily rely on quantitative comparisons of DNA methylation between normal and cancerous tissues 3–5. However, in clinical specimens such as cervical scrapes or self-collected samples, tumor-derived DNA is often mixed with a large background of normal DNA. This dilution effect can mask cancer-specific signals and lead to false negatives, highlighting the need for more sensitive detection methods.  \nSeveral studies have already examined DNA methylation markers in cervical scrapes and self-collected vaginal samples. Host-cell methylation markers have been highlighted for managing CIN 6; methylation assayshave been examined in self-collected samples 7, and HPV DNA methylation has been analyzed as a marker of  \n1EpiMedTech Global, Singapore, Singapore. 2MTL Epitherapeutics Inc., Montreal, Canada. 3Gerald Bronfman Department of Oncology, McGill University, Montréal, QC, Canada. 4Division of Cancer Epidemiology, McGill University, Montréal, QC, Canada. 5HKG epiTherapeutics Limited, Hong Kong, Hong Kong. 6 Lishui Joint Innovation Center for Life and Health, Zhejiang University, Hangzhou, China. 7 Lvgu Institute for Life and Health, Zhejiang University, Lishui, China. 􀀍 email: [David.cheishvili@epimedtech.com](David.cheishvili@epimedtech.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificrep","cbCaijb0wOBN7zga","https://ap.wps.com/l/cbCaijb0wOBN7zga","pdf",1167781,"English","# Introduction\n# Methods and HMH Profiling\n# Results and Performance Compared to Existing Methods\n# Implications for Non-invasive Diagnostics","[{\"question\":\"Why do existing DNA methylation detection methods have limited sensitivity in early cervical cancer?\",\"answer\":\"Early tumors yield low concentrations of cancer DNA, and clinical samples contain a large background of normal DNA. Ratio-based methods can smooth subtle methylation differences, producing false negatives when tumor signals are weak.\"},{\"question\":\"What is the Highly Methylated Haplotype (HMH) approach used in this study?\",\"answer\":\"HMH profiling captures highly methylated haplotypes at single-molecule resolution using next-generation sequencing. It distinguishes cancer-associated methylation patterns from sporadic methylation seen in non-cancerous tissues.\"},{\"question\":\"Which biomarkers were included in the gene panel and how did performance compare to other scoring methods?\",\"answer\":\"The panel included CA10, DPP10, FMN2, and HAS1. Haplotype-based scoring at pre-specified cutoffs achieved 89.9% sensitivity for invasive cancer with high specificity (about 94–98%), outperforming median and single-CpG approaches.\"}]","Enhancing the sensitivity of noninvasive cervical cancer detection using CpG methylation haplotype profiling | PDF",1790146325,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0156bd82a2d09ebf6aaea53471e1e806.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0bd6d5a8607550cff4d61f01175af3a.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ca13c3bae4953348f6f7b5a9e030202.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9ca10b5789aea0905c56778bae478f3.webp",980,1287]